The proposed $66-billion merger between CVS and Aetna – the most expensive healthcare deal to date – may cut down drug prices by eliminating the middlemen. The proposed deal is covered in depth by various publications. For example, Bloomberg News suggests that the merger could be the end of the pharmacy-benefit business. Reuters reports that